ABSTRACT Aim To estimate the prevalence of nosocomial infections in haematological patients hospitalised between 2020 and 2022, identify associated risk factors, and describe antibiotic use before and during hospitalisation. Background Studies integrating clinical, environmental, microbiological and pharmacological data in this population remain ...
Laura Cabrera‐Jaime +3 more
wiley +1 more source
<i>M. tuberculosis</i> Beijing Genotype Clusters: Impact on Tuberculosis Drug Resistance in Kazakhstan. [PDF]
Akhmetova A +5 more
europepmc +1 more source
GeneXpert MTB/RIF reports only rifampicin resistance, so a result of ‘rifampicin resistance not detected’ does not exclude isoniazid resistance. In this young man with hemoptysis and bilateral infiltrates, phenotypic drug susceptibility testing of bronchoalveolar lavage revealed isoniazid‐resistant, rifampicin‐susceptible tuberculosis after 1 month of ...
Hafiz Muhammad Faisal Nadeem +5 more
wiley +1 more source
High-risk without safeguards? The EU AI Act and the push for deregulation of medical AI. [PDF]
Van Kolfschooten H +2 more
europepmc +1 more source
Carbapenem and Multidrug Resistance Among Gram-Negative Bacilli in a County Emergency Clinical Hospital from Western Romania: A Retrospective Study, 2024-2025. [PDF]
Timis LV +8 more
europepmc +1 more source
Multidrug-Resistant Bloodstream Infections Before and After COVID-19: A Temporal Assessment of Outcomes and Resistance Across Two Eras in a Non-COVID Intensive Care Unit-The MATURATE ICU Study. [PDF]
Kefala S +9 more
europepmc +1 more source
When hospitals build their own AI: a comparison of the EU and US regulatory framework. [PDF]
Palmieri S, Minssen T, Cohen IG.
europepmc +1 more source
Antitumor Efficacy of Apatinib and Etoposide-Loaded D-α-Tocopheryl Polyethylene Glycol Succinate Mixed Micelles Against Multidrug-Resistant Ovarian Cancer Cells. [PDF]
Yoo MK +7 more
europepmc +1 more source

